A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer

We evaluated the sequential use of carboplatin, paclitaxel and topotecan in patients with advanced, previously untreated ovarian cancer. In total, 43 patients with advanced ovarian cancer and >1 cm residual disease were treated with sequential carboplatin (area-under-the-curve (AUC) 5 days 1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Guppy, A E, Nelstrop, A E, Foster, T, Agarwal, R, Seckl, M J, Rustin, G J S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410185/
https://www.ncbi.nlm.nih.gov/pubmed/14970858
http://dx.doi.org/10.1038/sj.bjc.6601618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410185/
https://www.ncbi.nlm.nih.gov/pubmed/14970858
http://dx.doi.org/10.1038/sj.bjc.6601618

Ejemplares similares